018485053

BIONDD

---

June 3, 2021

Trademark Summary

The trademark BIONDD was filed by Biograil ApS, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on June 9, 2021, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on September 9, 2021 by P&G Health Germany GmbH on Likelihood of confusion. the opponent was represented by Brunner, Renate and its proceedings were handled in English The second opposition filed on August 22, 2021 by Byondis B.V. on Likelihood of confusion. the opponent was represented by Konings, Petrus Nicolaas Maria and its proceedings were handled in English The third opposition filed on June 27, 2021 by Byondis B.V. on Likelihood of confusion. the opponent was represented by Konings, Petrus Nicolaas Maria and its proceedings were handled in English

It was designated 'Basic Application' for International Application 1742445 at the World Intellectual Property Organization (WIPO).

The application was filed in Danish, and Danish was also language of all opposition proceedings (English was selected as the second language).

Change of name and address of the trademark registration was recorded on August 21, 2024.

---

Goods And Services

• The mark was filed in class 5 with Ingestible drug delivery agents in the form of capsules to facilitate delivery of pharmaceuticals.
• The mark was filed in class 10 with following description of goods:
  
  1. Medical apparatus and instruments
  2. Ingestible devices that can be programmed to release medication doses for medical, dental or veterinary use
  3. Ingestible devices for use in medical diagnosis and treatment.
• The mark was filed in class 42 with following description of goods:
  
  1. Scientific research for medical purposes
  2. Medical laboratory services
  3. Consultancy relating to research and development in the field of ingestible devices
  4. Laboratory research services relating to oral delivery device of pharmaceuticals that cannot be absorbed from an ordinary tablet or capsule
  5. Scientific research and development
  6. Research and development of new products
  7. Clinical research
  8. Biological research, clinical research and medical research
  9. Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
  10. Scientific services.